← Back to Search

Device

Intrapulmonary Percussive Ventilation for Non-sputum Producer for Cystic Fibrosis

N/A
Recruiting
Led By Daniel Weiner, MD
Research Sponsored by Daniel J. Weiner
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 minutes
Awards & highlights

Study Summary

"This trial aims to find a better way to collect sputum from Cystic Fibrosis patients who have trouble producing it. Participants will use a device called the Volera MetaNeb System during

Who is the study for?
This trial is for adults with Cystic Fibrosis who struggle to produce sputum. Specific eligibility criteria are not provided, but typically participants must meet certain health standards and may be excluded based on factors that could interfere with the study or their safety.Check my eligibility
What is being tested?
The trial is testing the effectiveness of the Volara MetaNeb System in helping patients with Cystic Fibrosis produce sputum during a clinic visit. It's a small pilot study aimed at improving sputum collection methods.See study design
What are the potential side effects?
Potential side effects are not detailed, but generally, procedures like using the Volara MetaNeb System might cause discomfort, coughing, or fatigue due to increased respiratory effort.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Sufficient sputum quantity for a pellet

Trial Design

1Treatment groups
Experimental Treatment
Group I: Intrapulmonary Percussive Ventilation for Non-sputum ProducerExperimental Treatment1 Intervention
Unable to produce adequate amount of lower airway bacterial sampling for culture results in last year.

Find a Location

Who is running the clinical trial?

Daniel J. WeinerLead Sponsor
Daniel Weiner, MDPrincipal InvestigatorUPMC Children's Hospital of Pittsburgh
1 Previous Clinical Trials
10,600 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there currently ongoing patient enrollments for this clinical trial?

"As per clinicaltrials.gov, recruitment for this particular study is presently closed. The trial was initially listed on 3rd January 2024 and most recently modified on 13th March 2024. Despite this specific trial not actively enrolling participants, there are currently 403 other studies seeking eligible individuals to participate."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Intrapulmonary Percussive Ventilation for Sputum Induction in Adults With Cystic Fibrosis
Daniel J. Weiner 2024. "Intrapulmonary Percussive Ventilation for Sputum Induction in Adults With Cystic Fibrosis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06311292.
All > Cystic Fibrosis > Paid Studies Pittsburgh
~13 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top